Sorafenib In Egyptian Patients With Hepatocellular Carcinoma.

Condition:   Hepatocellular Carcinoma Intervention:   Drug: Sorafenib Tablets Sponsors:   Damanhour University;   Mransoura University Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials